Similar articles

• Effects of normal as compared with low hematocrit values in patients with cardiac disease undergoing hemodialysis and receiving epoetin.

  González F. González F. N Engl J Med. 1998 Dec 31;339(27):2023-4. N Engl J Med. 1998. PMID: 9882204 No abstract available.
• The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

  Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA. Besarab A, et al. N Engl J Med. 1998 Aug 27;339(9):584-90. doi: 10.1056/NEJM199808273390903. N Engl J Med. 1998. PMID: 9718377 Clinical Trial.
• The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.

  Berns JS, Fishbane S, Elzein H, Lynn RI, Deoreo PB, Tharpe DL, Meisels IS. Berns JS, et al. Hemodial Int. 2005 Jul;9(3):255-63. doi: 10.1111/j.1492-7535.2005.01139.x. Hemodial Int. 2005. PMID: 16191075
• Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.

  Mercuriali F. Mercuriali F. Semin Hematol. 1996 Apr;33(2 Suppl 2):18-20; discussion 21. Semin Hematol. 1996. PMID: 8723576 Review.
• Epoetin alfa use in gynecology. Past, present and future.

  Bachmann GA. Bachmann GA. J Reprod Med. 2001 May;46(5 Suppl):539-44. J Reprod Med. 2001. PMID: 11396388 Review.